Penbrook Management’s Intermolecular, Inc. IMI Stock Holding History

Penbrook Management’s Portfolio IMI Stock Details IMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-30,000	Closed	-$34K	–	109
2019 Q1	$34K	Hold	30,000	–	–	0.04%	106
2018 Q4	$30K	Sell	30,000 -10,000	-25%	-$10K	0.03%	105
2018 Q3	$47K	Hold	40,000	–	–	0.05%	108
2018 Q2	$67K	Buy	+40,000	New	+$54.6K	0.06%	105

Other funds holding IMI

RCM

Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $449M AUM 51.52% 1-Year Est. Return

Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

GCIA

Gabelli & Co Investment Advisers Rye, New York $688M AUM 63.39% 1-Year Est. Return

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

WIC

Water Island Capital New York $1.08B AUM 105.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HIM

HGC Investment Management Toronto, Ontario, Canada $507M AUM 6.15% 1-Year Est. Return

KPF

K2 Principal Fund Toronto, Ontario, Canada $1.36B AUM 25.58% 1-Year Est. Return

Penbrook Management's IMI Position: Q2 2019 in Review

Penbrook Management sold out of Intermolecular, Inc. (IMI) in Q2 2019, closing a stake of 30,000 shares — an estimated $34K sold.

Penbrook Management first reported a position in IMI in Q2 2018 and held it in 4 quarters. The position peaked at $67K in Q2 2018. 40 funds tracked by Wall St. Rank hold IMI as of Q2 2019.

Penbrook Management reported no remaining Intermolecular, Inc. position as of Q2 2019 after selling out during the quarter.
Penbrook Management sold 30,000 Intermolecular, Inc. shares in Q2 2019, an estimated $34K.
Penbrook Management first reported a position in Intermolecular, Inc. in Q2 2018 and held it in 4 quarters.
Penbrook Management's Intermolecular, Inc. position peaked at $67K in Q2 2018.
40 funds tracked by Wall St. Rank held Intermolecular, Inc. as of Q2 2019.

Based on Penbrook Management's 13F filing for Q2 2019, filed 15 Jul 2019.